Abstract
Study objectives
The aim was to investigate the association between MMP16 rs60298754 and symptoms of Parkinson’s disease (PD) in southern Chinese.
Methods
Seven hundred forty-five PD patients were recruited in this study. All patients were evaluated by Brief Pain Inventory (BPI), Hamilton anxiety rating scale and Hamilton depression rating scale, 39-item Parkinson’s disease Questionnaire (PDQ-39), and MDS—Unified PD Rating Scale (MDS-UPDRS). Symptoms were also recorded.
Results
The difference of BPI and Parkinson’s disease sleep scale (PDSS) between two groups was showed (BPI: MMP16 wildtypes: 14.73 ± 14.45; MMP16 carriers: 10.95 ± 10.67, p 0.002; PDSS: MMP16 wildtypes: 117.80 ± 21.45; MMP16 carriers: 108.40 ± 23.95, p < 0.001). The association of apathy, nocturia, and sensitive to light were found (apathy: p 0.001, OR: 0.49, 0.32—0.76; nocturia: p < 0.001, OR: 3.57, 1.90—7.26; sensitive to light: p < 0.001, OR: 3.99, 2.01—7.74).
Conclusions
MMP16 rs60298754 was associated with the presence of apathy, pain, nocturia, and sensitive to light.
Similar content being viewed by others
References
Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996):896–912
Bene R et al (2009) Parkinson’s disease. ActaClin Croat 48(3):377–380
Jiang T et al (2018) The challenge of the pathogenesis of parkinson’s disease: is autoimmunity the culprit? Front Immunol 9:2047
Franco-Iborra S, Vila M, Perier C (2016) The parkinson disease mitochondrial hypothesis: where are we at? Neuroscientist 22(3):266–277
Chang D et al (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet 49(10):1511–1516
Houlden H, Singleton AB (2012) The genetics and neuropathology of Parkinson’s disease. ActaNeuropathol 124(3):325–338
Koros C, Simitsi A, Stefanis L (2017) Genetics of Parkinson’s disease: genotype-phenotype correlations. Int Rev Neurobiol 132:197–231
Fu R et al (2017) Fatigue correlates with LRRK2 G2385R variant in Chinese Parkinson’s disease patients. Parkinsonism RelatDisord 44:101–105
Gaig C et al (2014) Nonmotor symptoms in LRRK2 G2019S associated Parkinson’s disease. PLoS ONE 9(10):e108982
Nalls MA et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 46(9):989–993
Kapoor C et al (2016) Seesaw of matrix metalloproteinases (MMPs). J Cancer Res Ther 12(1):28–35
Wang X, Khalil RA (2018) Matrix metalloproteinases, vascular remodeling, and vascular disease. AdvPharmacol 81:241–330
MacCallum CA, Russo EB (2018) Practical considerations in medical cannabis administration and dosing. Eur J Intern Med 49:12–19
Russo R et al (2018) Gut-brain axis: role of lipids in the regulation of inflammation, pain and CNS diseases. Curr Med Chem 25(32):3930–3952
Li G et al (2018) Association of GALC, ZNF184, IL1R2 and ELOVL7 With Parkinson’s Disease in Southern Chinese. Front Aging Neurosci 10:402
Shin JI et al (2011) The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura. Br J Dermatol 164(6):1348–1355
Anttila V et al (2013) Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 45(8):912–917
Sintas C et al (2015) Replication study of previous migraine genome-wide association study findings in a Spanish sample of migraine with aura. Cephalalgia 35(9):776–782
Finley MJ et al (2013) Intracellular signaling mechanisms associated with CD47 modified surfaces. Biomaterials 34(34):8640–8649
Cao L et al (2016) MMP16 is a marker of poor prognosis in gastric cancer promoting proliferation and invasion. Oncotarget 7(32):51865–51874
Tatti O et al (2015) MMP16 mediates a proteolytic switch to promote cell-cell adhesion, collagen alignment, and lymphatic invasion in melanoma. Can Res 75(10):2083–2094
Zhang W, Chen CJ, Guo GL (2018) MiR-155 promotes the proliferation and migration of breast cancer cells via targeting SOCS1 and MMP16. Eur Rev Med PharmacolSci 22(21):7323–7332
Roth L et al (2017) A new role of the membrane-type matrix metalloproteinase 16 (MMP16/MT3-MMP) in neural crest cell migration. Int J DevBiol 61(3–4–5):245–256
Wang M et al (2014) N-cadherin is a novel ERα anchor that protects against 6-OHDA damage to dopaminergic cells. Cell MolNeurobiol 34(1):123–131
Huang B et al (2018) Polydatin prevents lipopolysaccharide (LPS)-induced Parkinson’s disease via regulation of the AKT/GSK3β-Nrf2/NF-κB signaling axis. Front Immunol 9:2527–2527
Acknowledgments
We thank all the patients who participated in this study.
Funding
This study was funded by the National Natural Science Foundation of China [grant numbers 81601010, 81701039, 81870843]; Young Excellent Talents in Tongji University (22120180604), Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai [Grant No. PWZxq2017-08] and the Outstanding Leaders Training Program of Pudong new area health system of Shanghai [Grant No. PWRl2018-01].
Author information
Authors and Affiliations
Contributions
Kui Chen and Meng-Ruo Guo collected the PD and control data, performed the statistical analysis and drafted the manuscript. Yue Zhang and Gang Li collected the PD data. Bei Zhang and Yi Liu designed the study, supervised the study, double-checked the statistical analysis and revised the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the ethic committee of Shanghai East hospital. All participants signed consent forms.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, K., Guo, MR., Zhang, Y. et al. Association between MMP16 rs60298754 and clinical phenotypes of Parkinson’s disease in southern Chinese. Neurol Sci 42, 3211–3215 (2021). https://doi.org/10.1007/s10072-020-04894-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04894-5